Inventor
WIERENGA WENDELL
US35 patents
⚠️ This page may combine multiple inventors who share the name “WIERENGA WENDELL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UPJOHN CO
33 patentsUS4978757ADec 18, 1990
1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds
UPJOHN CO61 citations96
US4975537ADec 4, 1990
Δ9(11) -angiostatic steroids
UPJOHN CO60 citations96
US4912227AMar 27, 1990
1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
UPJOHN CO73 citations96
US4771042ASep 13, 1988
Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
UPJOHN CO87 citations94
US4413132ANov 1, 1983
Antibiotic CC-1065 indoline intermediates
UPJOHN CO20 citations82
US4235887ANov 25, 1980
Process for therapeutic treatment
UPJOHN CO22 citations82
US4140850AFeb 20, 1979
2,2'-Anhydrotriazine nucleosides and process for preparing the same
UPJOHN CO20 citations82
US4086254AApr 25, 1978
Photocleavable steroids
UPJOHN CO22 citations82
US4948533AAug 14, 1990
11a-hydroxy steroid diester
UPJOHN CO20 citations80
US4590211AMay 20, 1986
Process for therapeutic treatment
UPJOHN CO7 citations74
US4460589AJul 17, 1984
Process for treating hypertension
UPJOHN CO8 citations74
US4423229ADec 27, 1983
Composition of matter and process
UPJOHN CO13 citations74
US4423228ADec 27, 1983
Process for preparing N-(methyl-sulfonyl)-1,2,8,8a-cyclopropa[c]benzo[1,2-b:4,3-b']dipyrrol-4(5H)-one
UPJOHN CO8 citations74
US4423230ADec 27, 1983
Preparation of an intermediate for N-(methylsulfonyl)-1,2,8,8a-cyclopropa[c][1,2-b:-4,3-b']dipyrol-4(5H)-one
UPJOHN CO7 citations74
US4400518AAug 23, 1983
Composition of matter and process
UPJOHN CO8 citations74
US4308272ADec 29, 1981
Process for treating hypertension
UPJOHN CO6 citations74
US4302456ANov 24, 1981
Process for therapeutic treatment
UPJOHN CO10 citations74
US4256898AMar 17, 1981
α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
UPJOHN CO14 citations74
US5434157AJul 18, 1995
6-aryl pyrimidine compounds and method for treating viral infections and inducing interferon production
UPJOHN CO15 citations73
US4507302AMar 26, 1985
Method for treating arthritis with 6-aryl pyrimidine compounds
UPJOHN CO14 citations72
US4593030AJun 3, 1986
Use of 6-aryluracils as antiinflammatory and antiarthritic agents
UPJOHN CO2 citations63
US4521599AJun 4, 1985
Process for the preparation of 1,3-oxazine-4-ones
UPJOHN CO2 citations63
US4496492AJan 29, 1985
Substituted phenylalkyl compounds
UPJOHN CO2 citations63
US4495349AJan 22, 1985
6-Aryluracils
UPJOHN CO4 citations63
US4455430AJun 19, 1984
Process for preparing tricholomic acid and derivatives thereof
UPJOHN CO2 citations63
US4431820AFeb 14, 1984
6-Methoxy indoline acetate and its 5-nitro and 5-amino derivatives
UPJOHN CO5 citations63
US4424365AJan 3, 1984
1,2,8,8a-Cyclopropa c!benzo 1,2,-b:-4,3-b'!dipyrrol-4(5H)-ones
UPJOHN CO5 citations63
US4302457ANov 24, 1981
Process for therapeutic treatment
UPJOHN CO6 citations63
US4298744ANov 3, 1981
Method for preparing (αS,5S)-α-amino-3-chloro-2-isoxazoline-5-acetic acid (AT-125) and analogs thereof
UPJOHN CO3 citations63
US4275214AJun 23, 1981
Substituted alkoxy carbonyl-3-oxo-α-phthalimido-5-isoxozolidineacetic acids
UPJOHN CO4 citations63
US4795812AJan 3, 1989
4-substituted-6-aryl-pyrimidine compounds
UPJOHN CO0 citations52
US4593096AJun 3, 1986
Novel compounds and process for treating hypertension
UPJOHN CO1 citations52
US4578466AMar 25, 1986
Processes for the preparation of 6-aryluracils
UPJOHN CO0 citations42
WARNER LAMBERT CO
2 patentsUS5633287AMay 27, 1997
N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
WARNER LAMBERT CO68 citations96
US5491172AFeb 13, 1996
N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
WARNER LAMBERT CO63 citations96